Colorectal Cancer Clinical Trials in Houston, TX

Colorectal Cancer Clinical Trials in Houston, TX

View the best 10 colorectal cancer medical studies in Houston, Texas. Access promising new therapies by applying to a Houston-based Colorectal Cancer clinical trial.

Trials in Houston, Texas

Here are the top 6 medical studies for colorectal cancer in Houston, Texas

Image of University of Oklahoma Health Sciences in Oklahoma City, United States.

ATX-559

DHX9 Inhibitor

Recruiting1 awardPhase 1
This trial aims to find a safe dose of a new drug called ATX-559 that is taken by mouth. It will also look at how the drug is processed in the body, its effects on
Image of NEXT Dallas in Irving, United States.

RMC-6291 +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial tests if two new drugs are safe and effective to treat cancers with a specific gene mutation.
Image of City of Hope National Medical Center in Duarte, United States.

Sotorasib +1 More

Small Molecule Drug

Recruiting2 awardsPhase 3
This trial is testing two doses of sotorasib combined with panitumumab in patients with a specific type of colorectal cancer that has not responded to other treatments. Sotorasib targets a genetic mutation in the cancer cells, while panitumumab helps the immune system attack the cancer. The goal is to see if this combination can help patients live longer without their cancer getting worse.
Image of South Texas Accelerated Research Therapeutics, LLC in San Antonio, United States.

FMC-376

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial will test a drug called FMC-376 in patients with advanced solid tumors that have a specific genetic mutation. The trial will have three parts to determine the safety and effectiveness of the drug at
Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Leucovorin Calcium, Fluorouracil, Oxaliplatin

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing whether adding atezolizumab to standard chemotherapy works better than chemotherapy alone for patients with stage III colon cancer who have a specific genetic defect. The chemotherapy drugs aim to kill cancer cells, while atezolizumab helps the immune system attack the cancer. Researchers hope this combination will improve survival rates and quality of life for these patients.
Image of NRG Oncology - Pittsburgh Center in Pittsburgh, United States.

mFOLFIRINOX

Recruiting1 awardPhase 2 & 3
This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.